Retatrutide Study Targets Cardiovascular and Kidney Outcomes in Obesity | Retatrutide News

The TRIUMPH-Outcomes study is assessing retatrutide's impact on heart and kidney health in obese adults. The trial will last about five years and involv...
Clinical Trials · November 2, 2026